From Sample to Insight: The Role of Advanced Laboratory Science in Modern Drug Development explores how advances in laboratory science are helping transform early-phase and translational research. From next-generation sequencing (NGS) and digital PCR (ddPCR) to automation, custom assay development and integrated specialty laboratory services, the eBook examines the technologies and approaches enabling sponsors to generate deeper insights from valuable clinical samples.
Drawing on hVIVO's experience across infectious disease, immunology and early-phase drug development, the eBook also explores the importance of integrating laboratory strategy with clinical and scientific expertise from the outset to generate robust, decision-ready data.
In this eBook, discover:
- Why NGS is becoming an important tool in early-phase infectious disease research, providing deeper insight into pathogen evolution, antiviral resistance and host response.
- How ddPCR and NGS can work together to strengthen viral surveillance, improve sensitivity and make more effective use of limited clinical samples.
- How laboratory automation is transforming workflows, improving throughput, consistency and reproducibility while reducing hands-on processing.
- Why custom assay development can help de-risk drug development, creating fit-for-purpose analytical tools aligned with a therapeutic's mechanism of action and regulatory questions.
- The advantages of centralised and specialty laboratory services, including access to advanced technologies, multidisciplinary expertise, scalability and integrated analytical approaches.
- How translational research can uncover meaningful biomarkers, including insights from controlled human challenge studies into host responses during different stages of respiratory viral infection.
Meet the Author
With 25 years of strategic and operational leadership across global drug development and manufacturing, Chris brings extensive experience to hVIVO’s Laboratory Services. His expertise spans building high-performing teams, developing robust operational frameworks and creating strong client partnerships across the UK, EU and US. In this eBook, Chris draws on that experience to explore how advanced laboratory science, technology and integrated expertise can help generate meaningful insights throughout drug development.
.png)
Our Accreditations
Good Clinical Practice (GCP)
Good Clinical Practice (GCP) is an international ethical and scientific quality standard; for designing, conducting, recording and reporting trials. Ensuring participant safety prevails over the interests of science and society.
Human Tissue Authority (HTA)
hVIVO is accredited by the Human Tissue Authority (HTA), meaning that we have been recognized by the HTA as compliant with standards and regulations for the ethical and legal removal, storage, and use of human tissue. A HTA license is essential, as hVIVO handles human tissue for various research purposes.
Good Clinical Laboratory Practice (GCLP)
All clinical trials comply with GCP and/or GCP for Laboratories (GCLP) guidance. Human Challenge Agent-only clinical studies that do not involve IMP also comply with GCP/GCLP.
hVIVO is a UKAS accredited Testing Laboratory No. 27882
